Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D004347:Drug Interactions; D010134:Fenclonine / Q000008:administration & dosage / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D008238:Lysergic Acid Diethylamide / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008636:Mesencephalon / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D010042:Ouabain / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium
D014316:Tritium; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D010042:Ouabain; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D010293:Pargyline; D010134:Fenclonine